# Supermicrosurgical Lymphvenous Bypass Intervention for Treatment

> **NCT05270629** · — · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 87 (estimated)

## Conditions studied

- Lymphedema of Leg

## Interventions

- **OTHER:** Antegrade and retrograde anastomoses
- **OTHER:** Antegrade-only anastomoses

## Key facts

- **NCT ID:** NCT05270629
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-06
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-09-05
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270629, "Supermicrosurgical Lymphvenous Bypass Intervention for Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05270629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*